Orbimed Advisors LLC Repare Therapeutics Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,322,488 shares of RPTX stock, worth $4.29 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,322,488
Previous 3,322,488
-0.0%
Holding current value
$4.29 Million
Previous $11.4 Million
61.92%
% of portfolio
0.12%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$13.3 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.44 Million1.93% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.83 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.41 Million5.13% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2MShares$2.58 Million0.02% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $54.1M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...